Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results

M. Gross-Goupil, T. G. Kwon, M. Eto, D. Ye, H. Miyake, S. I. Seo, S. S. Byun, J. L. Lee, V. Master, J. Jin, R. Debenedetto, R. Linke, M. Casey, B. Rosbrook, M. J. Lechuga Frean, O. Valota, E. Grande, D. I. Quinn

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii303
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this